Recombinant Soluble CD32 Suppresses Disease Progression in Experimental Epidermolysis Bullosa Acquisita
Journal of Investigative Dermatology - United Kingdom
doi 10.1038/jid.2014.451
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2015
Authors
Publisher
Elsevier BV